Vertex Pharma (VRTX): Raising PT - Morgan Stanley

May 18, 2017 8:29 AM EDT Send to a Friend
Morgan Stanley analyst, Matthew Harrison, reiterated his Overweight rating on shares of Vertex (NASDAQ: VRTX) and raised the price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login